ArticleActa pharmaceutica Sinica. B2024

Enhancing immunotherapy efficacy against MHC-I deficient triple-negative breast cancer using LCL161-loaded macrophage membrane-decorated nanoparticles.

Wen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.